NASDAQ · SLSNConsumer StaplesCosmetics & Personal Care

Solesence, Inc. Common Stock (SLSN)

$0.9140+6.76%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$0.86▼ 73.52% in range
Nov 3, 2025Low $0.64 · High $3.28Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

Solesence closed at $0.91 on Nov 4, up 6.76%, 72.1% below its 52-week closing high. Volume of 23.6K shares was 0.62× its 20-day average (below normal).

Split-adjusted performance: +14.2% over one month, -27.5% over six months, -71.7% over one year.

In the quarter ended Jun 30, 2026, revenue was $15.33M, down 24.7% from a year earlier, with a net margin of -1.0%.

Short interest was 367.8K shares at the Oct 15 settlement, down 3.6% from the prior report (2.1% of float, 7.6 days to cover).

Market cap$64.6M70.6M shares
Revenue · quarter$15.3M−24.7% YoY
Diluted EPS$0.00−100.0% YoY
P/E · TTM—P/S 1.2×
Net margin-1.0%Gross 31.0%
Dividend yieldNone
52-week range0.64 – 3.28−72.1% from high
Volume23.6K0.62× 20-day avg
Volatility · 60d68.3%Annualised
Short % of float2.1%7.6 days to cover
Net cash-$3.7MCash $1.0M
Next earnings—Not scheduled
Split-adjusted performance
1W +12.0%1M +14.2%3M −11.3%6M −27.5%YTD −42.7%1Y −71.7%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Cosmetics & Personal Care

Percentile among 12 companies (100 = best)

6-month momentum18
Revenue growth0
Net margin30
Value (low P/E)—
Size46

Industry medians: 6-month return +7.1%, revenue growth +3.4%, net margin 6.3%, P/E 30.9×.

Short interest

Details →
Shares short367.8K−3.6% vs prior
Days to cover7.6Settled Oct 15
% of float2.1%
Short vol. 10d36.5%of daily volume

Closest peers by size in Cosmetics & Personal Care

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
SLSNSolesence$0.9140+6.76%−27.5%−24.7%−1.0%—$64.6M
AXILAXIL Brands$5.60−2.78%−17.4%−11.2%6.9%13.7$38.2MCompare
UGUnited-Guardian$6.86+0.44%+2.2%+9.5%23.4%12.8$31.5MCompare
CABRCaring Brands$0.9000−26.83%−4.5%———$9.4MCompare
BNKKBonk$1.16+6.42%−56.9%—−520.4%—$9.2MCompare
YCBDcbdMD$0.4060−3.10%−55.5%+20.6%−21.6%—$4.5MCompare
EPCEdgewell Personal Care$29.66+6.19%+32.5%+1.7%2.4%—$1.37BCompare
COTYCOTY$3.47+5.47%+30.9%+1.3%−11.4%—$3.06BCompare
IPARInterparfums$123.57+5.53%+30.3%+2.1%8.9%23.6$3.96BCompare

Quick answers

What does Solesence do?
Solesence Inc is a health-oriented, science-driven company, focused on various skin health, beauty and wellness markets. Its primary skin health products are fully developed prestige skin care formulations with mineral-based UV protection enabled by proprietary Active Pharmaceutical Ingredients, which are also marketed as APIs for sale to manufacturers of other types of skin health products, including sunscreens and daily care products.
What is SLSN's market cap?
$64.57M, based on the Nov 4 close of $0.91.
Does Solesence pay a dividend?
No regular cash dividend has been paid in the last year.
How much of SLSN is sold short?
367.8K shares, 2.1% of float, as of Oct 15, 2026.
What sector is SLSN in?
Consumer Staples, in the Cosmetics & Personal Care industry.

About Solesence

Solesence Inc is a health-oriented, science-driven company, focused on various skin health, beauty and wellness markets. Its primary skin health products are fully developed prestige skin care formulations with mineral-based UV protection enabled by proprietary Active Pharmaceutical Ingredients, which are also marketed as APIs for sale to manufacturers of other types of skin health products, including sunscreens and daily care products. Additionally, it continues to sell products in legacy markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. The company operates as a single business segment.

HQ: Romeoville, IL115 employeesListed Nov 26, 1997solesence.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology